The rule, which is part of President Donald Trump's blueprint to rein in high drug costs, sparked immediate push back from pharmaceutical companies. Beyond the industry, experts are skeptical that the regulation would do anything to bring down prices and may confuse patients because consumers often don't pay the list price for medications.
from Kaiser Health News https://ift.tt/2Ck1AHW
October 16, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Addiction Medicine Mostly Prescribed To Whites, Even As Opioid Deaths Rose Among Blacks… Read More
White Patients 35 Times More Likely To Receive Addiction Medication Than African-American OnesThe findings on the racial disparity of treatment are critical as research revealed earlier this year showed a spike in the number of African-American deaths tied to fentanyl. Other news reports on the epidemic looks at needl… Read More
First Edition: May 9, 2019Today's early morning highlights from the major news organizations. from Kaiser Health News http://bit.ly/2WvN5YE … Read More
Study Results Encourage Collecting ‘Big Data’ During Annual Visit To Doctor To Detect Hidden Health ProblemsStudying genome and molecular activities in patients is better than conventional medicine when it comes to detecting potential health problems, according to Michael Snyder, chair of the genetics department at Stanford Univers… Read More
Needle Exchanges Find New Champions Among Republicans… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment